References
-
1
Cook D J, Guvatt G H, Salena B J, Laine L A.
Endoscopic therapy for nonvariceal uppergastrointestinal hemorrhage: a meta-analysis.
Gastroenterology.
1992;
102
139-148
-
2
Barkun A, Bardou M, Marshall J K et al.
Consensus recommendations for managing patientswith nonvariceal upper gastrointestinal bleeding.
Ann Intern Med.
2003;
139
843-857
-
3
Sung J J, Kelvin K K, Lai L H et al.
Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis.
Gut.
2007;
56
1364-1373
-
4
Alam H B, Burris D, DaCorta J A, Rhee P.
Hemorrhage control in the battlefield: role of newhemostatic agents.
Mil Med.
2005;
170
63-69
-
5
Pozza M, Millner R W.
Celox (chitosan) for haemostasis in massive traumatic bleeding:experience in Afganistan.
Eur J Emerg Med.
2011;
18
31-33
-
6
Giday S A, Kim Y, Krishnamurty D M et al.
Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.
Endoscopy.
2011;
43
295-208
-
7
Sung J JY, Luo D, Wu J CY et al.
Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding.
Endoscopy.
2011;
43
290-294
B. WeustenMD
Department of Gastroenterology and Hepatology
St Antonius Ziekenhuis
Koekoekslaan 1
Nieuwegein, NL-3435CM
Netherlands
Fax: +31–30–6093859
eMail: b.weusten@antoniusziekenhuis.nl
